Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Brigitte, Ganter"'
Autor:
Brigitte Ganter, Joseph S. Lipsick
Publikováno v:
Oncogene. 15:193-202
In vitro and in vivo methods were combined to determine the function of the three Myb binding sites (NrasI, NrasII and NrasIII) within the promoter region of the mouse N-ras gene. We found that the c-Myb DNA-binding domain can bind with high affinity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed1e347ca1a4016c4321201cac62af9
https://doi.org/10.1038/sj.onc.1201173
https://doi.org/10.1038/sj.onc.1201173
Autor:
Sunil Abhyankar, Jianwen Fang, Irfan Saadi, Nathan R. Wilson, Adam J. Olm-Shipman, Syed K. Rafi, Rodrigo T. Calado, Brigitte Ganter, Majed Dasouki, L. Mike Furness
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
We recently identified 2 siblings afflicted with idiopathic, autosomal recessive aplastic anemia. Whole-exome sequencing identified a novel homozygous missense mutation in thrombopoietin (THPO, c.112C>T) in both affected siblings. This mutation encod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633b7946f68ca11daa193cd77413104c
Publikováno v:
Journal of Molecular Biology. 234:975-987
Dimethyl sulfate, DNase I and micrococcal nuclease DNA cleavage were combined with the ligation-mediated polymerase chain reaction to obtain high resolution maps of the promoter regions for two cell-type-specific genes: the a-specific STE2 gene and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f65fa035536e0a9fbce52dc2c31ec2
https://doi.org/10.1006/jmbi.1993.1652
https://doi.org/10.1006/jmbi.1993.1652
Autor:
Karol L. Thompson, Michael Boedigheimer, Yaron Turpaz, Barry A. Rosenzweig, LH Reid, Brigitte Ganter, G Delenstarr, WD Jones, YD He, Kurt Jarnagin, PS Pine
Publikováno v:
Pharmacogenomics. 9(11)
Effective use of microarray technology in clinical and regulatory settings is contingent on the adoption of standard methods for assessing performance. The MicroArray Quality Control project evaluated the repeatability and comparability of microarray
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::023864b0d965f6cefa8284ac61aa133b
https://pubmed.ncbi.nlm.nih.gov/19018728
https://pubmed.ncbi.nlm.nih.gov/19018728
Autor:
Brigitte Ganter, Antoaneta Vladimirova
Publikováno v:
Toxicogenomics: A Powerful Tool for Toxicity Assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55a9626f0a3b17dcb7e06895877588d7
https://doi.org/10.1002/9780470699638.ch6
https://doi.org/10.1002/9780470699638.ch6
Autor:
Brigitte, Ganter, Craig N, Giroux
Publikováno v:
Current opinion in drug discoverydevelopment. 11(1)
Molecular pathway and network analysis tools that have been developed over the past decade provide an emerging systems-wide perspective for the analysis of gene expression, proteomic and metabolomic data. These tools link relevant extracted literatur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b53e6fd9adcddef79ac371cfbfbdf102
https://pubmed.ncbi.nlm.nih.gov/18175271
https://pubmed.ncbi.nlm.nih.gov/18175271
Publikováno v:
Pharmacogenomics. 9(1)
The pharmaceutical industry has begun to leverage a range of new technologies (proteomics, pharmacogenomics, metabolomics and molecular toxicology [e.g., toxicogenomics]) and analysis tools that are becoming increasingly integrated in the area of dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be16d2e899ec7da7d2808d954c25ce25
https://pubmed.ncbi.nlm.nih.gov/18154447
https://pubmed.ncbi.nlm.nih.gov/18154447
Publikováno v:
The FASEB Journal. 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff8e5cf6c99ea70a2c1ae916aa5fccd4
https://doi.org/10.1096/fasebj.21.5.a416-b
https://doi.org/10.1096/fasebj.21.5.a416-b
Publikováno v:
Molecular Cancer, Vol 5, Iss 1, p 54 (2006)
Molecular Cancer
Molecular Cancer
Genes that cause cancer have been divided into two general classes – oncogenes that act in a dominant fashion to transform normal cells into a malignant state, and tumor suppressor genes that act in a dominant fashion to prevent such transformation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faebabbfc5c01caa355640c5eb007f7a
http://www.molecular-cancer.com/content/5/1/54
http://www.molecular-cancer.com/content/5/1/54
Publikováno v:
Pharmacogenomics. 7(7)
A range of genomics technologies are increasingly becoming integrated with existing scientific disciplines to broaden and strengthen existing capabilities and open new avenues of research in drug discovery and development. Examples of these new resea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3bab863fd1734ef8cfce59b06700817
https://pubmed.ncbi.nlm.nih.gov/17054413
https://pubmed.ncbi.nlm.nih.gov/17054413